Innova CaptabInnova Captab LimitedNSE:INNOVACAPMicrocap_Investorπ¨ STOCK TO WATCH π¨ βΉ1,050ββΉ1,060 β βΉ1,374 β βΉ1,530 β βΉ3,113 π A fast-growing integrated pharmaceutical player appearing on my Weekly R4 Breakout Scanner. Innova Captab Ltd. π Buy Zone: βΉ1,050ββΉ1,060 π Breakout Zone: βΉ1,060 π Stop Loss: βΉ710 π― Target 1: βΉ1,374 π― Target 2: βΉ1,530 π― Target 3: βΉ3,113 Why Innova Captab? π Integrated pharma platform: The company operates across CDMO and Branded Generics, covering research, development, manufacturing and market-facing pharma operations. π Strong CDMO franchise: CDMO revenue reached βΉ1,133.35 Cr in FY26, growing 23.8% YoY, with 350+ customers across 60+ countries. π Branded Generics acceleration: FY26 Branded Generics revenue reached βΉ496.67 Cr, representing 51.4% YoY growth. π Capacity expansion: The company has manufacturing facilities across Baddi, Dehradun, Taloja and Kathua, with further investment in manufacturing and R&D capabilities. π Export opportunity: Exports contributed 31.3% of FY26 revenue, with presence across 60+ countries and growing access to regulated markets. π Weekly Camarilla R4 Breakout Setup Why It Caught My Attention β Strong CDMO growth β 51%+ Branded Generics growth β 350+ global customers β Expanding manufacturing capacity β Growing international exposure β Weekly R4 Momentum Breakout β οΈ High Risk β High Reward Setup. Always follow strict stop-loss and disciplined position sizing. π’ Disclaimer: This content is for educational purposes only and not investment advice. Please do your own due diligence before making any investment decisions. Risk Defined. Reward Visible. Β© 20K Microcap Investing | R4 Momentum Desk #InnovaCaptab #PharmaStocks #CDMO #Pharmaceuticals #PharmaIndia #HealthcareStocks #StockMarketIndia #IndianStocks #StocksToWatch #R4Breakout #MomentumInvesting #20KMicrocap